High-flow Nasal Cannula Market
High-flow Nasal Cannula Market Study by Air/Oxygen Blenders, Air Humidifiers, Single Heated Tubes, and Nasal Cannulas from 2023 to 2033
Analysis of High-flow Nasal Cannula Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
High-flow Nasal Cannula Market Outlook (2023 to 2033)
Global sales of high-flow nasal cannulas are estimated to increase at a prolific CAGR of 12% from 2023 to 2033. The market is valued at US$ 7.7 billion in 2023 and is thus expected to reach US$ 24 billion by 2033-end.
Hospitals are preferred by patients suffering from chronic obstructive pulmonary diseases due to their advanced healthcare facilities. High-flow nasal cannulas are widely used in hospitals to provide respiratory treatments because they provide benefits such as the reduced risk of infection and an ideal flow rate.
An oxygen delivery system called a high-flow nasal cannula can deliver up to 100% heated, humidified oxygen at a flow rate of up to 60 liters per minute. High-flow nasal cannulas are gaining popularity as alternate respiratory support for seriously ill patients.
High-flow nasal cannulas are effective for treating hypercapnic respiratory failure and mild to severe hypoxemic respiratory failure, in addition to respiratory diseases, including asthma and chronic obstructive pulmonary disease (COPD). The increasing prevalence of asthma and COPD worldwide as well as the growing elderly population are the elements driving market expansion.
Smoking prevalence and air pollution levels have been rising globally in recent years, in both developed and developing countries. Asthma causes the airways to swell, become more constricted, and produce mucus. Wheezing, coughing, and repeated episodes of breathlessness are other consequences of this, and the degree and regularity of these episodes vary from person to person. It is estimated that 235 million people worldwide have asthma, according to the World Health Organization.
Shortness of breath, chest tightness, a persistent cough, respiratory infections, wheezing, and other symptoms are all long-term effects of chronic obstructive pulmonary disease, a lung disease. The market for high-flow nasal cannulas is expanding as a result of factors such as the rising prevalence of lung cancer as well as the rising demand for heated humidified high-flow nasal cannulas.
Additionally, one of the reasons driving the market growth is corporate investments in R&D initiatives that aim to develop better goods and more advanced technology. The market is expanding as a result of the expanding popularity of oxygen therapy and the advancement of developing new techniques.
Market share is expected to increase due to the special benefits of high-flow nasal cannulas and the patients' increasing acceptance of this treatment approach. During the projection period, it is also anticipated that the market for high-flow nasal cannulas would grow due to the increasing prevalence of sleep apnea. In clinical practice, high-flow oxygen therapy (HFOT) delivered using a nasal cannula has been shown to be safe and beneficial in providing respiratory support with acceptable airway humidity.
Report Attributes |
Details |
|
High-flow Nasal Cannula Market Size (2023) |
US$ 7.7 Billion |
|
Projected Market Value (2033) |
US$ 24 Billion |
|
Global Market Growth Rate (2023 to 2033) |
12% CAGR |
|
Market Share of Nasal Cannulas |
60% |
|
Key Companies Profiled |
|
Why are Sales of High-flow Nasal Cannulas Surging across the World?
“Growing Geriatric Population Driving Global Demand for High-flow Nasal Cannulas”
The elderly population is especially prone to many respiratory illnesses. As a result, the expansion of the worldwide high-flow nasal cannula market will be aided by the expanding geriatric population.
Asthma and COPD are more common among the elderly than the younger population, and their effects on quality of life are particularly severe. As the senior population expands, so will the incidence of COPD and asthma. In addition, there will be an increase in hospital admissions and treatments. Considering that older people widely utilize high-flow nasal cannula products for respiratory care, this will lead to a rise in demand for these products.
“Constant Innovations in High-flow Nasal Cannula Systems”
Technological advancements by key market players are also anticipated to boost the market. Moreover, clinical trials for evaluating new application areas shall open up new avenues for the market.
Innovative high-flow nasal cannula products that are safer and more convenient to use than conventional devices have been made available due to new developments in technology. With more patients throughout the world adopting this, the market is growing faster.
High-velocity nasal insufflation systems and the creation of a single-use patient interface for high-flow oxygen treatment delivery in hospital settings are two significant industry advances. The benefits connected to high-flow nasal cannulas such as the assistance these devices offer in reducing breathing frequency and work of breathing and the reduction of the necessity of respiratory support escalation have put the market towards a positive growth outlook over the coming years.
Don't Need a Global Report?
save 40%! on Country & Region specific reports
Which Obstacles Should High-flow Nasal Cannula Producers Overcome?
“High Price of High-flow Nasal Cannulas and Availability of Substitutes”
There are several risks to take into account before using any form of additional oxygen. Long-term use has been linked to respiratory issues, eye impairment, and pulmonary oxygen toxicity, which happens when the body receives too much oxygen and can harm the lungs. The high price of high-flow nasal cannulas compared to standard oxygen cannulas and increased complexity could impede market expansion, according to pricing trends.
There are numerous alternative options on the market, which are expected to restrain the growth of the nasal cannula market over the forecast period. For instance, the market may be hampered by the availability of solutions such as full-face masks and complete masks with tubing that can be utilized to give oxygen to the patient.
Why is Demand for High-flow Nasal Cannulas High in North America?
“Growing Preference for Non-invasive Ventilation”
North America accounts for over 50% share of the total market value. Growing preference for non-invasive ventilation (NIV) and continuous positive airway pressure (CPAP) devices has augmented rapidly in home care settings for patients suffering from respiratory diseases in North America. This has stimulated key manufacturers to increase the production of high-flow nasal cannula devices, thus increasing the market share.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
Country-wise Insights
Why is the United States Commanding the North American Market?
“Advancements in Nasal Cannula Treatments across the Country”
The market in the United States is anticipated to have many potential prospects due to the advancements in nasal cannula treatments. Market growth is attributed to many factors, including the presence of well-established healthcare facilities, an increase in the local supply of air humidifiers, and growing public awareness of advanced medical technologies.
Why are Manufacturers of High-flow Nasal Cannulas Earning More Profits in Germany?
“Rising Prevalence of Premature Births in the Country”
Germany shows impressive growth prospects for the high-flow nasal cannula market during the forecast period. The rising prevalence of premature births is anticipated to fuel the market growth over the forecast period. An increase in investments by government organizations for the treatment of such respiratory illnesses and expanding R&D efforts are driving market growth in Germany.
Why is Japan a Prominent Market for High-flow Nasal Cannulas?
“Favorable Healthcare & Reimbursement Policies in Japan”
The market in Japan is projected to expand at a CAGR of 11% over the forecast period. The increasing population, degraded air quality, and growing smoking prevalence have increased the prevalence of respiratory disease cases. The presence of top market participants and rising healthcare expenditure, favorable healthcare and reimbursement policies, and improving healthcare standards are supporting market expansion.
Category-wise Insights
Which Component is Projected to Account for Substantial Revenue Generation?
“Nasal Cannulas Widely Used for Providing Respiratory Supportive Care with Appropriate Airway Humidity”
Based on component, the market is divided into air/oxygen blenders, air humidifiers, single heated tubes, nasal cannulas, and others. Nasal cannulas account for 60% share of the global market owing to the rising prevalence of respiratory diseases.
An individual who is unable to obtain enough oxygen for sustained normal body function is given oxygen via a nasal cannula. A flexible plastic tube called a nasal cannula has two tiny prongs that slide into the nostrils. It is utilized to provide a patient with a high flow of oxygen. The prongs are attached to a tank or wall outlet that provides oxygen. A flow meter on the oxygen supply controls the flow of oxygen.
A patient receives more oxygen from high-flow nasal cannulas than from a conventional cannula. This can be advantageous for those who require more oxygen to maintain their health, such as those with chronic respiratory diseases such as COPD or asthma.
Which Application is Likely to Contribute the Most to Market Expansion?
“High-flow Nasal Cannulas Preferred for Acute Respiratory Failure Treatment”
Based on the application, the market is classified into acute respiratory failure, chronic obstructive pulmonary disease (COPD), carbon monoxide toxicity, bronchiectasis, sleep apnea, and others. The use of high-flow nasal cannulas in acute respiratory failure treatment is increasing due to their unique advantages and the growing acceptance of these devices among patients suffering from acute respiratory disorders.
Moreover, high-flow nasal cannula devices can also help in sleep apnea treatment by delivering a consistent flow of oxygen via the nasal cannula and alleviating upper airway obstruction. The rising prevalence of sleep apnea is also anticipated to boost the market of high-flow nasal cannulas.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Competitive Landscape
Top high-flow nasal cannula providers are consistently innovating their product portfolios through technological advancements to acquire market presence. Key market players are making high investments in R&D projects to enhance quality control of products using advanced technologies and following safety regulations to reduce the environmental impact.
Major high-flow nasal cannula manufacturers are focusing on producing top-notch cannulas and distributing them to clinics, hospitals, and healthcare institutions. Leading companies in the high-flow nasal cannula market use a variety of strategies to boost sales across numerous geographies, including improving product standards, collaborations, and supply chain management.
For instance,
- Fisher & Paykel Healthcare is a leading player in the global high-flow nasal cannula market. Its flagship products include F&P 950 Humidifier, Optiflow High-flow System, and the AIRVO 2. Other products include OptiFlowTM Nasal High, F&P Brevida Masks, and the F&P SimplusTM Full Face Masks.
- ResMed Inc. is another market leader in the respiratory therapy market. It offers a strong product portfolio for the treatment of sleep apnea and non-invasive ventilation. Its flagship products include AirView, myAir, and ClimateLine MAX for the treatment and management of sleep apnea and respiratory disorders.
- In August 2021, ResMed introduced AirSense 11, its newest positive airway pressure (PAP) device for treating and controlling obstructive sleep apnea.
Key Segments of High-Flow Nasal Cannula Industry Research
-
By Component :
- Air/Oxygen Blenders
- Air Humidifiers
- Single Heated Tubes
- Nasal Cannulas
- Others
-
By Application :
- Acute Respiratory Failure
- Chronic Obstructive Pulmonary Disease (COPD)
- Carbon Monoxide Toxicity
- Bronchiectasis
- Sleep Apnea
- Others
-
By End User :
- Hospitals
- Long-term Care Centers
- Ambulatory Care Centers
- Others
-
By Region :
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Table of Content
1. Preface 1.1. Report Scope and Market Segmentation 1.2. Research Highlights 2. Assumptions and Research Methodology 2.1. Assumptions and Acronyms Used 2.2. Research Methodology 3. Executive Summary 3.1. Global Market Size (US$ Mn) and Forecast, by Region, 2023 and 2033 3.2. Global Market: Market Snapshot 4. Market Overview 4.1. Global Market Overview 4.2. Global Market Key Industry Developments 4.3. Key Industry Events 5. Market Dynamics 5.1. Drivers and Restraints Snapshot Analysis 5.2. Drivers 5.3. Restraints 5.4. Opportunities 5.5. Key Trends 5.6. Global Market Revenue Projections (US$ Mn), 2023–2033 5.7. Market: Mergers & Acquisitions 5.8. Heat Map Analysis - Company 6. Global Market Analysis, by Component 6.1. Introduction 6.2. Key Insights 6.3. Global Market Size and Forecast, by Component 6.3.1. Air/Oxygen Blend 6.3.2. Air Humidifier 6.3.3. Single Heated Tube 6.3.4. Nasal Cannula 6.3.5. Other Consumables 6.4. Global Market Analysis, by Component 6.5. Global Market Attractiveness Analysis, by Component 7. Global Market Analysis, by End User 7.1. Introduction 7.2. Key Insights 7.3. Global Market Size and Forecast, by End User 7.3.1. Hospitals 7.3.2. Long-term Care Centers 7.3.3. Ambulatory Care Centers 7.3.4. Tomosynthesis 7.3.5. Others End User 7.4. Global Market Analysis, by End User 7.5. Global Market Attractiveness Analysis, by End User 8. Global Market Analysis, by Applications 8.1. Introduction 8.2. Key Insights 8.3. Global Market Size and Forecast, by Applications 8.3.1. Acute Respiratory Failure 8.3.2. Chronic Obstructive Pulmonary Disease (COPD) 8.3.3. Carbon Monoxide Toxicity 8.3.4. Bronchiectasis 8.3.5. Sleep Apnea 8.3.6. Acute Respiratory Failure 8.3.7. Other Applications 8.4. Global Market Analysis, by Applications 8.5. Global Market Attractiveness Analysis, by Applications 9. Global Market Analysis, by Region 9.1. Introduction 9.2. Key Insights 9.3. Global Market Size and Forecast , by Region, 2023–2033 9.3.1. North America 9.3.2. Europe 9.3.3. Asia Pacific 9.3.4. Latin America 9.3.5. Middle East & Africa 9.4. Global Market Analysis, by Region 9.5. Global Market Attractiveness Analysis, by Region 10. North America Market Analysis 10.1. North America Market Key Findings 10.2. North America Market Overview 10.3. North America Market Size and Forecast, by Component 10.3.1. Air/Oxygen Blend 10.3.2. Air Humidifier 10.3.3. Single Heated Tube 10.3.4. Nasal Cannula 10.3.5. Other Consumables 10.3.6. North America Market Analysis, by Component 10.4. North America Market Size and Forecast, by End User 10.4.1. Hospital Based Laboratories 10.4.2. Diagnostic laboratories 10.4.3. Specialty Clinics 10.4.4. Others 10.5. North America Market Forecast, by Applications 10.5.1. Acute Respiratory Failure 10.5.2. Chronic Obstructive Pulmonary Disease (COPD) 10.5.3. Carbon Monoxide Toxicity 10.5.4. Bronchiectasis 10.5.5. Sleep Apnea 10.5.6. Acute Respiratory Failure 10.5.7. Other Applications 10.6. North America Market Forecast, by Country 10.6.1. U.S. 10.6.2. Canada 10.7. North America Market Attractiveness Analysis 10.7.1. By Component 10.7.2. By End User 10.7.3. By Applications 10.7.4. By Country 11. Europe Market Analysis 11.1. Europe Market Key Findings 11.2. Europe Market Overview 11.3. Europe Market Size and Forecast, by Component 11.3.1. Air/Oxygen Blend 11.3.2. Air Humidifier 11.3.3. Single Heated Tube 11.3.4. Nasal Cannula 11.3.5. Other Consumables 11.4. Europe Market Size and Forecast, by End User 11.4.1. Hospitals 11.4.2. Long-term Care Centers 11.4.3. Ambulatory Care Centers 11.4.4. Tomosynthesis 11.4.5. Others End User 11.5. Europe Market Forecast, by Applications 11.5.1. Acute Respiratory Failure 11.5.2. Chronic Obstructive Pulmonary Disease (COPD) 11.5.3. Carbon Monoxide Toxicity 11.5.4. Bronchiectasis 11.5.5. Sleep Apnea 11.5.6. Acute Respiratory Failure 11.5.7. Other Applications 11.6. Europe Market Forecast, by Country 11.6.1. Germany 11.6.2. U.K. 11.6.3. France 11.6.4. Spain 11.6.5. Italy 11.6.6. Rest of Europe 11.7. Europe Market Attractiveness Analysis 11.7.1. By Component 11.7.2. By End User 11.7.3. By Applications 11.7.4. By Country 12. Asia Pacific Market Analysis 12.1. Asia Pacific Market Key Findings 12.2. Asia Pacific Market Overview 12.3. Asia Pacific Cytometry Market Size and Forecast, by Component 12.3.1. Air/Oxygen Blend 12.3.2. Air Humidifier 12.3.3. Single Heated Tube 12.3.4. Nasal Cannula 12.3.5. Other Consumables 12.4. Asia Pacific Market Size and Forecast, by End User 12.4.1. Hospitals 12.4.2. Long-term Care Centers 12.4.3. Ambulatory Care Centers 12.4.4. Tomosynthesis 12.4.5. Others End User 12.5. Asia Pacific Market Forecast, by Applications 12.5.1. Acute Respiratory Failure 12.5.2. Chronic Obstructive Pulmonary Disease (COPD) 12.5.3. Carbon Monoxide Toxicity 12.5.4. Bronchiectasis 12.5.5. Sleep Apnea 12.5.6. Acute Respiratory Failure 12.5.7. Other Applications 12.6. Asia Pacific Market Forecast, by Country 12.6.1. China 12.6.2. India 12.6.3. Japan 12.6.4. Australia & New Zealand 12.6.5. Rest of Asia Pacific 12.7. Asia Pacific Market Attractiveness Analysis 12.7.1. By Component 12.7.2. By End User 12.7.3. By Applications 12.7.4. By Country 13. Latin America Market Analysis 13.1. Latin America Market Key Findings 13.2. Latin America Market Overview 13.3. Latin America Cytometry Market Size and Forecast, by Component 13.3.1. Air/Oxygen Blend 13.3.2. Air Humidifier 13.3.3. Single Heated Tube 13.3.4. Nasal Cannula 13.3.5. Other Consumables 13.4. Latin America Market Size and Forecast, by End User 13.4.1. Hospitals 13.4.2. Long-term Care Centers 13.4.3. Ambulatory Care Centers 13.4.4. Tomosynthesis 13.4.5. Others End User 13.5. Latin America Market Forecast, by Country 13.5.1. Brazil 13.5.2. Mexico 13.5.3. Rest of Latin America 13.6. Latin America Market Forecast, by Applications 13.6.1. Acute Respiratory Failure 13.6.2. Chronic Obstructive Pulmonary Disease (COPD) 13.6.3. Carbon Monoxide Toxicity 13.6.4. Bronchiectasis 13.6.5. Sleep Apnea 13.6.6. Acute Respiratory Failure 13.6.7. Other Applications 13.7. Latin America Market Attractiveness Analysis 13.7.1. By Component 13.7.2. By End User 13.7.3. By Applications 13.7.4. By Country 14. Middle East & Africa Market Analysis 14.1. Middle East & Africa Market Key Findings 14.2. Middle East & Africa Market Overview 14.3. Middle East & Africa Cytometry Market Size and Forecast, by Component 14.3.1. Air/Oxygen Blend 14.3.2. Air Humidifier 14.3.3. Single Heated Tube 14.3.4. Nasal Cannula 14.3.5. Other Consumables 14.4. Middle East & Africa Market Size and Forecast, by End User 14.4.1. Hospitals 14.4.2. Long-term Care Centers 14.4.3. Ambulatory Care Centers 14.4.4. Tomosynthesis 14.4.5. Others End User 14.5. Middle East & Africa Market Forecast, by Applications 14.5.1. Acute Respiratory Failure 14.5.2. Chronic Obstructive Pulmonary Disease (COPD) 14.5.3. Carbon Monoxide Toxicity 14.5.4. Bronchiectasis 14.5.5. Sleep Apnea 14.5.6. Acute Respiratory Failure 14.5.7. Other Applications 14.6. Middle East & Africa Market Size and Forecast, by Country 14.6.1. GCC Countries 14.6.2. Israel 14.6.3. South Africa 14.6.4. Rest of Middle East & Africa 14.7. Middle East Market Attractiveness Analysis 14.7.1. By Component 14.7.2. By End User 14.7.3. By Applications 14.7.4. By Country 15. Competition Landscape 15.1. Global Market Share Analysis, by Company (2022) 15.2. Company Profiles 15.2.1. Flexicare Medical Limited 15.2.1.1. Overview (HQ, Employee Strength, Business Segments) 15.2.1.2. Financials 15.2.1.3. Recent Developments 15.2.1.4. Strategy 15.2.2. Teijin Pharma Limited 15.2.2.1. Overview (HQ, Employee Strength, Business Segments) 15.2.2.2. Financials 15.2.2.3. Recent Developments 15.2.2.4. Strategy 15.2.3. Vapotherm 15.2.3.1. Overview (HQ, Employee Strength, Business Segments) 15.2.3.2. Financials 15.2.3.3. Recent Developments 15.2.3.4. Strategy 15.2.4. Salter Labs 15.2.4.1. Overview (HQ, Employee Strength, Business Segments) 15.2.4.2. Financials 15.2.4.3. Recent Developments 15.2.4.4. Strategy 15.2.5. Teleflex Incorporated 15.2.5.1. Overview (HQ, Employee Strength, Business Segments) 15.2.5.2. Financials 15.2.5.3. Recent Developments 15.2.5.4. Strategy 15.2.6. Fisher & Paykel Healthcare Limited 15.2.6.1. Overview (HQ, Employee Strength, Business Segments) 15.2.6.2. Financials 15.2.6.3. Recent Developments 15.2.6.4. Strategy 15.2.7. ResMed, Inc. 15.2.7.1. Overview (HQ, Employee Strength, Business Segments) 15.2.7.2. Financials 15.2.7.3. Recent Developments 15.2.7.4. Strategy 15.2.8. Smiths Medical 15.2.8.1. Overview (HQ, Employee Strength, Business Segments) 15.2.8.2. Financials 15.2.8.3. Recent Developments 15.2.8.4. Strategy 15.2.9. Hamilton Medical 15.2.9.1. Overview (HQ, Employee Strength, Business Segments) 15.2.9.2. Financials 15.2.9.3. Recent Developments 15.2.9.4. Strategy 15.2.10. TNI Medical AG 15.2.10.1. Overview (HQ, Employee Strength, Business Segments) 15.2.10.2. Financials 15.2.10.3. Recent Developments 15.2.10.4. Strategy
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 01: Global Market Revenue (US$ Mn) Forecast, by Component, 2023–2033
Table 02: Global Market Revenue (US$ Mn) Forecast, by Application, 2023–2033
Table 03: Global Market Revenue (US$ Mn) Forecast, by End-user, 2023–2033
Table 04: Global Market Revenue (US$ Mn) Forecast, by Region, 2023–2033
Table 05: North America Market Revenue (US$ Mn) Forecast, by Country, 2023–2033
Table 06: North America Market Revenue (US$ Mn) Forecast, by Component, 2023–2033
Table 07: North America Market Revenue (US$ Mn) Forecast, by Application, 2023–2033
Table 08: North America Market Revenue (US$ Mn) Forecast, by End-user, 2023–2033
Table 09: Europe Market Revenue (US$ Mn) Forecast, by Country, 2023–2033
Table 10: Europe Market Revenue (US$ Mn) Forecast, by Component, 2023–2033
Table 11: Europe Market Revenue (US$ Mn) Forecast, by Application, 2023–2033
Table 12: Europe Market Revenue (US$ Mn) Forecast, by End-user, 2023–2033
Table 13: Asia Pacific Market Revenue (US$ Mn) Forecast, by Country, 2023–2033
Table 14: Asia Pacific Market Revenue (US$ Mn) Forecast, by Component, 2023–2033
Table 15: Asia Pacific Market Revenue (US$ Mn) Forecast, by Application, 2023–2033
Table 16: Asia Pacific Market Revenue (US$ Mn) Forecast, by End-user, 2023–2033
Table 17: Latin America Market Revenue (US$ Mn) Forecast, by Country, 2023–2033
Table 18: Latin America Market Revenue (US$ Mn) Forecast, by Component, 2023–2033
Table 19: Latin America Market Revenue (US$ Mn) Forecast, by Application, 2023–2033
Table 20: Latin America Market Revenue (US$ Mn) Forecast, by End-user, 2023–2033
Table 21: Middle East & Africa Market Revenue (US$ Mn) Forecast, by Country, 2023–2033
Table 22: Middle East & Africa Market Revenue (US$ Mn) Forecast, by Component, 2023–2033
Table 23: Middle East & Africa Market Revenue (US$ Mn) Forecast, by Application, 2023–2033
Table 24: Middle East & Africa Market Revenue (US$ Mn) Forecast, by End-user, 2023–2033
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 01: Global Market Size (US$ Mn) Forecast, 2023–2033
Figure 02: Global Market Value Share, by Application (2022)
Figure 03: Global Market Value Share, by Component (2022)
Figure 04: Global Market Value Share, by End User (2022)
Figure 05: Global Market Value Share, by Region (2022)
Figure 06: Global Market Value Share, by Component, 2023 and 2033
Figure 07: Global Market Attractiveness, by Component, 2023–2033
Figure 08: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Air/Oxygen Blender, 2023–2033
Figure 09: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Active Humidifier, 2023–2033
Figure 10: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Single Heated Tube, 2023–2033
Figure 11: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Nasal Cannula, 2023–2033
Figure 12: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Other Consumables, 2023–2033
Figure 13: Global Market Value Share, by Application, 2023 and 2033
Figure 14: Global Market Revenue (US$ Mn) and Y-o-Y Growth Projection (%), by Acute Respiratory Failure Application, 2023–2033
Figure 15: Global Market Revenue (US$ Mn) and Y-o-Y Growth Projection (%), by Chronic Obstructive Pulmonary Disease Application, 2023–2033
Figure 16: Global Market Revenue (US$ Mn) and Y-o-Y Growth Projection (%), by Acute Heart Failure Application, 2023–2033
Figure 17: Global Market Revenue (US$ Mn) and Y-o-Y Growth Projection (%), by Carbon Monoxide Toxicity Application, 2023–2033
Figure 18: Global Market Revenue (US$ Mn) and Y-o-Y Growth Projection (%), by Sleep Apnea Application, 2023–2033
Figure 19: Global Market Revenue (US$ Mn) and Y-o-Y Growth Projection (%), by Bronchiectasis Application, 2023–2033
Figure 20: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Other Applications, 2023–2033
Figure 21: Global Market Attractiveness, by Application, 2023–2033
Figure 22: Global Market Value Share, by End-user, 2023 and 2033
Figure 23: Global Market Attractiveness, by End-user, 2023–2033
Figure 24: Global Market Revenue (US$ Mn) and Y-o-Y Growth Projection (%), by Hospitals, 2023–2033
Figure 25: Global Market Revenue (US$ Mn) and Y-o-Y Growth Projection (%), by Long-term Care Centers, 2023–2033
Figure 26: Global Market Revenue (US$ Mn) and Y-o-Y Growth Projection (%), by Ambulatory Care Centers, 2023–2033
Figure 27: Global Market Revenue (US$ Mn) and Y-o-Y Growth Projection (%), by Other End Users, 2023–2033
Figure 28: Global Market Value Share, by Region, 2023 and 2033
Figure 29: Global Market Attractiveness, by Region, 2023–2033
Figure 30: North America Market Revenue (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2023–2033
Figure 31: North America Market Value Share, by Country, 2023 and 2033
Figure 32: North America Market Attractiveness, by Country, 2023–2033
Figure 33: North America Market Value Share, by Component, 2023 and 2033
Figure 34: North America Market Attractiveness, by Component, 2023–2033
Figure 35: North America Market Value Share, by Application, 2023 and 2033
Figure 36: North America Market Attractiveness, by Application, 2023–2033
Figure 37: North America Market Value Share, by End-user, 2023 and 2033
Figure 38: North America Market Attractiveness, by End-user, 2023–2033
Figure 39: Europe Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2023–2033
Figure 40: Europe Market Value Share, by Country, 2023 and 2033
Figure 41: Europe Market Attractiveness, by Country, 2023–2033
Figure 42: Europe Market Value Share, by Component, 2023 and 2033
Figure 43: Europe Market Attractiveness, by Component, 2023–2033
Figure 44: Europe Market Value Share, by Application, 2023 and 2033
Figure 45: Europe Market Attractiveness, by Application, 2023–2033
Figure 46: Europe Market Value Share, by End-user, 2023 and 2033
Figure 47: Europe Market Attractiveness, by End-user, 2023–2033
Figure 48: Asia Pacific Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%), 2023–2033
Figure 49: Asia Pacific Market Value Share, by Country, 2023 and 2033
Figure 50: Asia Pacific Market Attractiveness, by Country, 2023–2033
Figure 51: Asia Pacific Market Value Share, by Component, 2023 and 2033
Figure 52: Asia Pacific Market Attractiveness, by Component, 2023–2033
Figure 53: Asia Pacific Market Value Share, by Application, 2023 and 2033
Figure 54: Asia Pacific Market Attractiveness, by Application, 2023–2033
Figure 55: Asia Pacific Market Value Share, by End-user, 2023 and 2033
Figure 56: Asia Pacific Market Attractiveness, by End-user, 2023–2033
Figure 57: Latin America Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%), 2023–2033
Figure 58: Latin America Market Value Share, by Country, 2023 and 2033
Figure 59: Latin America Market Attractiveness, by Country, 2023–2033
Figure 60: Latin America Market Value Share, by Component, 2023 and 2033
Figure 61: Latin America Market Attractiveness, by Component, 2023–2033
Figure 62: Latin America Market Value Share, by Application, 2023 and 2033
Figure 63: Latin America Market Attractiveness, by Application, 2023–2033
Figure 64: Latin America Market Value Share, by End-user, 2023 and 2033
Figure 65: Latin America Market Attractiveness, by End-user, 2023–2033
Figure 66: Middle East & Africa Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2023–2033
Figure 67: Middle East & Africa Market Value Share, by Country, 2023 and 2033
Figure 68: Middle East & Africa Market Attractiveness, by Country, 2023–2033
Figure 69: Middle East & Africa Market Value Share, by Component, 2023 and 2033
Figure 70: Middle East & Africa Market Attractiveness, by Component, 2023–2033
Figure 71: Middle East & Africa Market Value Share, by Application, 2023 and 2033
Figure 72: Middle East & Africa Market Attractiveness, by Application, 2023–2033
Figure 73: Middle East & Africa Market Value Share, by End-user, 2023 and 2033
Figure 74: Middle East & Africa Market Attractiveness, by End-user, 2023–2033
Figure 75: Global Market Share, by Company, 2022
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
At what pace is the high-flow nasal cannula market expected to increase over the coming years?
The global high-flow nasal cannula market is estimated to surge at a CAGR of 12% through 2033.
At present what valuation does the high-flow nasal cannula market enjoy?
Worldwide demand for high-flow nasal cannulas is currently valued at US$ 7.7 billion.
What are the key factors driving the sales of high-flow nasal cannulas?
Technological advancements in high-flow nasal cannulas and rising geriatric population are driving market expansion.
Which region is expected to hold a leading share of the global market?
North America accounts for 50% share of the global market.
Who are the key high-flow nasal cannula producers?
Hamilton Medical, ResMed Inc., and TNI Medical AG are leading high-flow nasal cannula providers.
High-flow Nasal Cannula Market